IKZF1 deletions associate with CRLF2 overexpression leading to a poor prognosis in B-cell precursor acute lymphoblastic leukaemia-Reference-Cited by-同舟云学术

IKZF1 deletions associate with CRLF2 overexpression leading to a poor prognosis in B-cell precursor acute lymphoblastic leukaemia

Published:2022-01 Issue:1 Volume:15 Page:101291
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Maciel Ana Luiza Tardem,Barbosa Thayana da Conceição,Blunck Caroline Barbieri,Wolch Karolyne,Machado Amanda de Albuquerque Lopes,da Costa Elaine Sobral,Bergier Lavínia Lustosa,Schramm Márcia Trindade,Ikoma-Coltutato Maura Rosane Valério,Lins Mecneide Mendes,Aguiar Thais Ferraz,Mansur Marcela Braga,Emerenciano Mariana

Funder

CNPq

FAPERJ

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference27 articles.

1. Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study;Chen;Blood,2012

2. CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemia;Palmi;Oncotarget,2016

3. New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemia;Moorman;Haematologica,2016

4. Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia;Russell;Blood,2009

5. Genomics in acute lymphoblastic leukaemia: insights and treatment implications;Roberts;Nat. Rev. Clin. Oncol.,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia;Frontiers in Oncology;2024-04-03

2. The application of targeted RNA sequencing for the analysis of fusion genes, gene mutations, IKZF1 intragenic deletion, and CRLF2 overexpression in acute lymphoblastic leukemia;International Journal of Laboratory Hematology;2024-03-29

3. How to Manage Philadelphia-Positive Acute Lymphoblastic Leukemia in Resource-Constrained Settings;Cancers;2023-12-10

4. Poor outcome of pediatric B-cell acute lymphoblastic leukemia associated with high level of CRLF2 gene expression in distinct molecular subtypes;Frontiers in Oncology;2023-11-07

5. Rare concomitance of ETV6::RUNX1 and BCR::ABL1p210 in a child diagnosed with B-cell precursor acute lymphoblastic leukemia;Cancer Genetics;2023-08